LIU JUN enters CURANEX PHARMACEUTICALS INC with 11.93M shares across direct and indirect positions
This filing by LIU JUN (CEO and President) establishes the baseline for all future Form 4 insider transaction reports at CURANEX PHARMACEUTICALS INC.
Direct Indirect
Filed: 9/2/2025ACC: 0001641172-25-026283
DirectorOfficer10% Owner· CEO and President
Since Aug 2025
11.93M
Baseline shares
63% direct
7.57M
Direct ownership
2 positions
0.00
Derivative underlying
0 instruments
5
Security positions
4.36M indirect
Non-Derivative Holdings5
Common Stock
IndirectShares owned912.60K
Series A Preferred Stock
IndirectShares owned200K
Series A Preferred Stock
DirectShares owned490K
Common Stock
DirectShares owned7.08M
Common Stock
IndirectShares owned3.25M
Total
7.57M direct·4.36M indirect11.93M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 912.60K | Indirect |
| Series A Preferred Stock | 200K | Indirect |
| Series A Preferred Stock | 490K | Direct |
| Common Stock | 7.08M | Direct |
| Common Stock | 3.25M | Indirect |
| Total | 11.93M | 7.57M direct·4.36M indirect |
Derivative Holdings0
No derivative holdings reported